Citi tells investors it’s time to sell Moderna after 600%-plus stock gains

The True Post icon

Revenue and profit forecasts fail to justify the hype baked into Moderna’s share price, according to Citi’s analysts.

Source: MarketWatch

Share This Article
The newsroom of The True Post.
Leave a Comment